The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.
Efficacy and tolerability of azilsartan combined with amlodipine and amlodipine monotherapy and combinations of amlodipine with other angiotensin II receptor blockers
Journal: Russian Cardiology Bulletin. 2024;19(4‑2): 161‑171
Views: 583
Downloaded: 34
To cite this article:
Gilyarevsky SR, Karpov YuA, Luchnikova EA, Lantsova EV. Efficacy and tolerability of azilsartan combined with amlodipine and amlodipine monotherapy and combinations of amlodipine with other angiotensin II receptor blockers. Russian Cardiology Bulletin.
2024;19(4‑2):161‑171. (In Russ.)
https://doi.org/10.17116/Cardiobulletin202419042161
To evaluate the efficacy and safety of combining various angiotensin II receptor blockers with amlodipine compared with amlodipine alone, as well as intake of azilsartan 20—80 mg daily and amlodipine 5—10 mg daily compared to other angiotensin II receptor blockers combined with amlodipine in patients with hypertension.
The review enrolled 22 clinical trials (21 RCTs and 1 observational study) and 9.708 patients. Among 21 RCTs, 19 studies were blinded and 2 RCTs were open-label.
We found more significant SBP decrease in case of combination of azilsartan with amlodipine compared to amlodipine alone (5 or 10 mg daily). Such advantages of combined antihypertensive therapy with azilsartan and amlodipine were more pronounced compared to combination of other ARBs with amlodipine. Moreover, these advantages of azilsartan combined with amlodipine were significantly clearer compared to valsartan or losartan.
We found higher antihypertensive efficacy of azilsartan combined with amlodipine in comparison with combination of other ARBs and amlodipine monotherapy. Despite higher antihypertensive efficacy of azilsartan combined with amlodipine, safety of this therapy did not differ from combination of other ARBs with amlodipine or amlodipine monotherapy.
Keywords:
Authors:
Received:
05.11.2024
Accepted:
11.11.2024
List of references:
Close metadata
Email Confirmation
An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.
Email Confirmation
Log in to the site using your account in one of the services
We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.